cas 1339892-67-9|| where to buy 2-(2-oxaspiro[3.3]heptan-6-ylidene)acetonitrile

Produktname:2-(2-oxaspiro[3.3]heptan-6-ylidene)acetonitrile

IUPAC Name:2-{2-oxaspiro[3.3]heptan-6-ylidene}acetonitrile

Packungseinheit	Verfügbarer Vorrat	Preis($)
CM1018229-250mg	in stock	ɅƀǊ
CM1018229-500mg	in stock	ƦƦțŴ
CM1018229-1g	in stock	ƦȬǊǊ

Nur für den Einsatz in Forschung und Entwicklung..

Anfrage-Formular

Chemische Bezeichnung

CAS-Nummer

Menge*

Erforderliche Spezifikationen*
(Gehalt %, Materialqualität etc.)

Name des Ansprechpartners*

E-Mail des Ansprechpartners*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 1339892-67-9 regularly via the above email.

Zusätzliche Hinweise

Verification code*

refresh

: CAS-Nr.:1339892-67-9; Molekulare Formel:C8H9NO; Schmelzpunkt:-; SMILES-Code:N#CC=C1CC2(COC2)C1; Dichte:

: Katalognummer:CM1018229; Molekulargewicht:135.17; Siedepunkt:; Mdl-Nr.:; Lagerung:

: Cyclobutanes; The molecular structure of cyclobutane has four carbon atoms, and its four carbon atoms are not in the same plane, which is the folded conformation of cyclobutane. Cyclobutane itself is not of commercial or biological interest, but more complex derivatives are important in biology and biotechnology. Currently, nine FDA-approved drugs contain the cyclobutane structure. From the perspective of therapeutic areas, cyclobutyl drugs are mainly distributed in popular areas such as tumors, neurological diseases, infectious diseases, endocrine and metabolic diseases.

: Oxetanes; Oxygen heterocycles are one of the most common heterocycles in drugs and natural products. Oxetene has high polarity and is also a good acceptor for hydrogen bond, which contributes to the metabolism and chemical stability of its host molecules. When substituted for commonly used functional groups such as gem dimethyl or carbonyl, oxetane units can induce profound changes in water solubility, lipophilicity, metabolic stability and conformational preference. Four of the FDA-approved drugs contain oxetenes: Orlistat, Paclitaxel, and two of its derivatives, Docetaxel and Cabazitaxel. Currently, oxetane-containing building blocks are flourishing in medicinal chemistry and drug discovery.